IMMUNOTHÉRAPIE S'APPLIQUANT AUX TUMEURS MALIGNES DES LYMPHOCYTES B ET MALADIE AUTO-IMMUNE ET UTILISANT DES ANTICORPS NON CONJUGUÉS ET DES ANTICORPS CONJUGUÉS, DES COMBINAISONS D'ANTICORPS ET DES PROTÉINES DE FUSION
The invention is directed to a method for treating an autoimmune disease in a mammal by concurrently or sequentially administering to the mammal a therapeutic composition that comprises a pharmaceutically acceptable vehicle and at least one conjugated antibody, wherein predosing with a non-radiolabeled antibody is not performed.